Literature DB >> 29222765

Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Jeetendra Kumar Nag1, Tatyana Rudina1, Myriam Maoz1, Sorina Grisaru-Granovsky1, Beatrice Uziely1, Rachel Bar-Shavit2.   

Abstract

G protein-coupled receptors (GPCRs) comprise the main signal-transmitting components in the cell membrane. Over the past several years, biochemical and structural analyses have immensely enhanced our knowledge of GPCR involvement in health and disease states. The present review focuses on GPCRs that are cancer drivers, involved in tumor growth and development. Our aim is to highlight the involvement of stabilized β-catenin molecular machinery with a specific array of GPCRs. We discuss recent advances in understanding the molecular path leading to β-catenin nuclear localization and transcriptional activity and their implications for future cancer therapy research.

Entities:  

Keywords:  Cancer; G protein-coupled receptors; β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29222765     DOI: 10.1007/s10555-017-9711-z

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  8 in total

1.  WNT-3A-induced β-catenin signaling does not require signaling through heterotrimeric G proteins.

Authors:  Carl-Fredrik Bowin; Asuka Inoue; Gunnar Schulte
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

2.  Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis.

Authors:  Lili Zhou; Shan Zhou; Peng Yang; Yuan Tian; Zhiwei Feng; Xiang-Qun Xie; Youhua Liu
Journal:  Kidney Int       Date:  2018-08-06       Impact factor: 10.612

3.  CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.

Authors:  Dan Zi; Qing Li; Cheng-Xiong Xu; Zhi-Wei Zhou; Guan-Bin Song; Cheng-Bin Hu; Fang Wen; Han-Lin Yang; Lei Nie; Xing Zhao; Jun Tan; Shu-Feng Zhou; Zhi-Xu He
Journal:  Aging (Albany NY)       Date:  2022-06-09       Impact factor: 5.955

4.  α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis.

Authors:  Aleena K S Arakaki; Wen-An Pan; Helen Wedegaertner; Ivette Roca-Mercado; Logan Chinn; Taranjit S Gujral; JoAnn Trejo
Journal:  J Cell Sci       Date:  2021-04-22       Impact factor: 5.285

Review 5.  Deregulation of Frizzled Receptors in Hepatocellular Carcinoma.

Authors:  Kristy Kwan-Shuen Chan; Regina Cheuk-Lam Lo
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

6.  FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation.

Authors:  Maria Principia Scavo; Nicoletta Depalo; Federica Rizzi; Chiara Ingrosso; Elisabetta Fanizza; Annarita Chieti; Caterina Messa; Nunzio Denora; Valentino Laquintana; Marinella Striccoli; Maria Lucia Curri; Gianluigi Giannelli
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

7.  NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.

Authors:  Raksha Bhat; Hariprasad Thangavel; Noor Mazin Abdulkareem; Suhas Vasaikar; Carmine De Angelis; Leon Bae; Maria Letizia Cataldo; Sarmistha Nanda; Xiaoyong Fu; Bing Zhang; Rachel Schiff; Meghana V Trivedi
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

8.  CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.

Authors:  Chuang Meng; Yue Zhang; Dujun Jiang; Jian Wang
Journal:  World J Surg Oncol       Date:  2022-03-20       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.